Syndax Pharmaceuticals Inc（SNDX）價格預測SNDXSyndax Pharmaceuticals Inc

Alphio's SNDX stock price prediction model matches the current Syndax Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.22 (+0.96%). The 1-week path is $13.29 (+1.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Syndax Pharmaceuticals is not a good buy right now due to significant recent setbacks and poor technical indicators. The stock is currently priced at $12.90, down 24.07% over the last 5 days, and has an RSI of 9.59, indicating it is heavily oversold. The failure of the axatilimab trial has led to a sharp decline in investor confidence, and the company's forward P/E ratio is currently at 0, reflecting uncertainty about future earnings. The main risk is the company's high debt-to-equity ratio of 3895.07%, which raises concerns about financial stability.

Syndax Pharmaceuticals Inc (SNDX) last closed at $13.09, gaining +1.47%. These facts feed the 1-day and 1-week SNDX price prediction above.